A recent study published in The Lancet has conducted a comparative analysis of cancer mortality rates between the United States and Dalian city in Liaoning province, China. The research utilized Dalian cancer registry data from 2015 to 2020, revealing insights into age-standardized 5-year survival rates for all cancer patients, which were lower in Dalian at 49.9% compared to the US rate of 67.9%. However, when examining individual cancer types, Dalian patients exhibited better survival rates for lung, bladder, and cervical cancers.<\/p>\n\n\n\n
International Collaboration on Cancer Research<\/strong>
The study was a collaborative effort by a global team of researchers from prestigious institutions, including the National Cancer Center attached to the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, the School of Public Policy and Administration at Chongqing University, the US Harvard T.H. Chan School of Public Health, and the Dalian Center for Disease Control and Prevention.<\/p>\n\n\n\n